pulmonary disorders
Community Acquired Pneumonia
Prevention of Community Acquired Pneumonia
Some forms of community-acquired pneumonia are preventable with vaccination. Pneumococcal vaccination is recommended for all healthy adults ≥ 65 years of age and adults 19 to 64 years of age with chronic medical conditions, immunocompromising illness, asplenia, or increased risk of meningitis. Several Pneumococcal Vaccine are available: 20-Valent pneumococcal conjugate vaccine (PCV20) is recommended as a single vaccine. Alternatively, a combination of 15-valent pneumococcal conjugate vaccine (PCV15) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) at least a year later can be used. The interval between the 2 vaccines can be shortened to 8 weeks or more in certain high-risk patients, such as those who are immunocompromised. A Childhood Vaccination Schedules (PCV13) is recommended for children age 2 months to 2 years. Additional doses of a pneumococcal PPSV23 are recommended for children from 2 to 18 years of age who are at increased risk for invasive pneumococcal disease. website. Recommendations for other vaccines, such as Haemophilus influenzae Type b (Hib) Vaccine (for patients In high-risk patients who are not vaccinated against influenza and household contacts of patients with influenza,oseltamivir75 mg orally once/day orzanamivir10 orally mg once/day can be given for 2 weeks. If started within 48 hours of exposure, these antivirals may prevent influenza (although resistance has been described foroseltamivir). Smoking Cessation can reduce the risk of developing pneumonia. 